D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
CRNX holding history
Crinetics Pharmaceuticals, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
CRNX overviewAll 13F holders of CRNXFull Q2 2026 holdings
- Shares (Q1 2025)
- 0
- Sold out in Q1 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 14
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2025 | 0 | $0 | 0.0% | −9,876−100.0% | Sold out | Holders |
| Q4 2024 | 9,876 | $505.0K | <0.1% | −55,813−85.0% | Reduced | Holders |
| Q3 2024 | 65,689 | $3.36M | <0.1% | +26,123+66.0% | Added | Holders |
| Q2 2024 | 39,566 | $1.77M | <0.1% | +32,666+473.4% | Added | Holders |
| Q1 2024 | 6,900 | $323.0K | <0.1% | −10,105−59.4% | Reduced | Holders |
| Q4 2023 | 17,005 | $605.0K | <0.1% | −29,440−63.4% | Reduced | Holders |
| Q3 2023 | 46,445 | $1.38M | <0.1% | −24,145−34.2% | Reduced | Holders |
| Q2 2023 | 70,590 | $1.27M | <0.1% | +70,590 | New | Holders |
| Q1 2023 | 0 | $0 | 0.0% | −31,417−100.0% | Sold out | Holders |
| Q4 2022 | 31,417 | $574.9K | <0.1% | −5,738−15.4% | Reduced | Holders |
| Q3 2022 | 37,155 | $730.0K | <0.1% | +9,162+32.7% | Added | Holders |
| Q2 2022 | 27,993 | $522.0K | <0.1% | +12,972+86.4% | Added | Holders |
| Q1 2022 | 15,021 | $330.0K | <0.1% | −51,761−77.5% | Reduced | Holders |
| Q4 2021 | 66,782 | $1.90M | <0.1% | +24,687+58.6% | Added | Holders |
| Q3 2021 | 42,095 | $886.0K | <0.1% | +10,863+34.8% | Added | Holders |
| Q2 2021 | 31,232 | $589.0K | <0.1% | +31,232 | New | Holders |